Active, not recruitingNot applicableNCT04296903

Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Studying NON RARE IN EUROPE: Juvenile idiopathic scoliosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Apifix
Intervention
MID-C System(device)
Enrollment
201 enrolled
Eligibility
10 years · All sexes
Timeline
20202030

Study locations (14)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04296903 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Juvenile idiopathic scoliosis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Juvenile idiopathic scoliosis

← Back to all trials